resumo
Cancer is one of the deadliest diseases worldwide and has been responsible for millions of deaths. However, developing a satisfactory smart multifunctional material combining different strategies to kill cancer cells poses a challenge. This work aims at filling this gap by developing a composite material for cancer treatment through hyperthermia and drug release. With this purpose, magnetic nanoparticles were coated with a polymer matrix consisting of poly (L-co-D,L lactic acid-co-trimethylene carbonate) and a poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer. High-resolution transmission electron microscopy and selected area electron diffraction confirmed magnetite to be the only iron oxide in the sample. Cytotoxicity and heat release assays on the hybrid nanoparticles were performed here for the first time. The heat induction results indicate that these new magnetic hybrid nanoparticles are capable of increasing the temperature by more than 5 degrees C, the minimal temperature rise required for being effectively used in hyperthermia treatments. The biocompatibility assays conducted under different concentrations, in the presence and in the absence of an external alternating current magnetic field, did not reveal any cytotoxicity. Therefore, the overall results indicate that the investigated hybrid nanoparticles have a great potential to be used as carrier systems for cancer treatment by hyperthermia.
palavras-chave
IRON-OXIDE NANOPARTICLES; IN-VITRO; HUMAN-ERYTHROCYTES; VIVO
categoria
Biochemistry & Molecular Biology; Chemistry
autores
Gomes, AA; Valverde, TM; Machado, VD; da Silva, ED; Fagundes, DA; Oliveira, FD; Freitas, ETF; Ardisson, JD; Ferreira, JMD; Oliveira, JAD; Gomes, ER; Rodrigues, CF; de Goes, AM; Domingues, RZ; Andrade, AL
nossos autores
José Maria da Fonte Ferreira
Professor(a) Jubilado(a)agradecimentos
The authors would like to thank the Universidade Federal de Ouro Preto (UFOP), Universidade Federal de Minas Gerais (UFMG), and Centro Nacional de Desenvolvimento da Energia Nuclear (CDTN/CNEN) for their scientific and financial support.